– Reuters
Related Posts
RBC Capital Maintains Outperform on Cognizant Tech Solns, Lowers Price Target to $88
RBC Capital analyst Daniel Perlin maintains Cognizant Tech Solns (NASDAQ:CTSH) with a Outperform and lowers the price target from $97 to $88.
Reported July 19, Select Medical Announces Preliminary Financial Results For Q2 In connection With Refinancing Discussions; Sees Q2 EPS $0.61 Vs $0.48 Est; Revenue $1.67B Vs $1.64B Est; $100M Of Cash And $3.75B Of Indebtedness On Its Balance Sheet
Select Medical Holdings Corporation ("Select Medical," "we," "us," or "our") (NYSE:SEM) is currently in discussions with its lenders regarding a proposed refinancing of
Top 5 Energy Stocks That May Explode In February
The most oversold stocks in the energy sector presents an opportunity to buy into undervalued companies.